{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:01:17Z","timestamp":1788289277867,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"am","delay-in-days":289,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.modpat.2025.100821","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:09:47Z","timestamp":1750208987000},"page":"100821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract"],"prefix":"10.1016","volume":"38","author":[{"given":"Rayan","family":"Rammal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florestan J.","family":"Koll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muneeb","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan E.","family":"Eichholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejiri","family":"Agbamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Basar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Yol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Sarungbam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson W.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Grisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Pietzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard H.","family":"Bochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopa","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Solit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-6627","authenticated-orcid":false,"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.modpat.2025.100821_bib1","first-page":"513","article-title":"Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases","volume":"9","author":"Oliva","year":"1996","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100821_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0046-8177(96)90064-7","article-title":"The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature","volume":"27","author":"Drew","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2025.100821_bib3","article-title":"Primary clear cell carcinoma of the urinary bladder","volume":"2014","author":"Venyo","year":"2014","journal-title":"Int Sch Res Notices"},{"issue":"7","key":"10.1016\/j.modpat.2025.100821_bib4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-07-4147","article-title":"Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin","volume":"14","author":"Sung","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib6","first-page":"615","article-title":"Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of Mullerian origin","volume":"33","author":"Lah","year":"2013","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.5858\/133.6.987","article-title":"Clear cell adenocarcinoma of the urinary bladder: a short review","volume":"133","author":"Adeniran","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365590510007630","article-title":"Clear cell adenocarcinoma of the urinary bladder","volume":"39","author":"K\u00f6sem","year":"2005","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/jcm9010138","article-title":"Clear cell adenocarcinoma of the urinary bladder is a glycogen-rich tumor with poorer prognosis","volume":"9","author":"Zhou","year":"2020","journal-title":"J Clin Medicine"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/PAS.0000000000001589","article-title":"Clear cell adenocarcinoma in men: a series of 15 cases","volume":"45","author":"Grosser","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100821_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(17)62554-0","article-title":"Mesonephric adenocarcinoma of the bladder","volume":"100","author":"Dow","year":"1968","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100821_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00000478-198511000-00005","article-title":"Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100821_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.5858\/2008-132-1417-CCAOUB","article-title":"Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S","volume":"132","author":"Sun","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.modpat.2025.100821_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0046-8177(98)90015-6","article-title":"Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison","volume":"29","author":"Gilcrease","year":"1998","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00000478-200202000-00005","article-title":"Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of Mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100821_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/PAS.0b013e31816b1020","article-title":"Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?","volume":"32","author":"Tong","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100821_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humpath.2009.10.011","article-title":"Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma","volume":"41","author":"Herawi","year":"2010","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100821_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.humpath.2011.01.007","article-title":"Hepatocyte nuclear factor-1beta expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis","volume":"42","author":"Brimo","year":"2011","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00428-019-02634-5","article-title":"Molecular profiling of clear cell adenocarcinoma of the urinary tract","volume":"475","author":"Lin","year":"2019","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/genes12060880","article-title":"Molecular characterization of muellerian tumors of the urinary tract","volume":"12","author":"Ortiz-Br\u00fcchle","year":"2021","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-012-1363-3","article-title":"Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems","volume":"462","author":"Alexiev","year":"2013","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13000-022-01269-6","article-title":"GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall","volume":"17","author":"Akgul","year":"2022","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib23","first-page":"51","article-title":"Clear cell adenocarcinoma of the urinary tract primary to the renal pelvis: a multi-institutional clinicopathologic and molecular study of five patients","volume":"49","author":"Indulkar","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4143\/crt.2023.577","article-title":"Clear cell adenocarcinoma of urethra: clinical and pathologic implications and characterization of molecular aberrations","volume":"56","author":"Song","year":"2024","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.modpat.2025.100821_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105767","article-title":"Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis","volume":"157","author":"Zheng","year":"2025","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100821_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization Classification of tumors of the urinary system and male genital organs-part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2025.100821_bib27","series-title":"Urinary and Male Genital Tumours","first-page":"188","article-title":"Clear cell adenocarcinoma of the urinary tract","author":"Brimo","year":"2022"},{"issue":"2","key":"10.1016\/j.modpat.2025.100821_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000343520","article-title":"The progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma: a case report","volume":"6","author":"Dhaliwal","year":"2012","journal-title":"Curr Urol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.humpath.2005.09.013","article-title":"Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma","volume":"37","author":"Hartmann","year":"2006","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100821_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2017.11.026","article-title":"The molecular functions of hepatocyte nuclear factors\u2014in and beyond the liver","volume":"68","author":"Lau","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100821_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PAP.0b013e31826663b1","article-title":"Clear cell carcinoma of the female genital tract (not everything is as clear as it seems)","volume":"19","author":"Offman","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.modpat.2025.100821_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1149875","article-title":"Review of neurodevelopmental disorders in patients with HNF1B gene variations","volume":"11","author":"Nittel","year":"2023","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PGP.0b013e318273fd07","article-title":"HNF-1beta in ovarian carcinomas with serous and clear cell change","volume":"32","author":"DeLair","year":"2013","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0b013e31824973d1","article-title":"Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma","volume":"20","author":"Fadare","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100821_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ajpath.2013.11.023","article-title":"Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing","volume":"184","author":"Mehra","year":"2014","journal-title":"Am J Pathol"},{"issue":"16","key":"10.1016\/j.modpat.2025.100821_bib37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.modpat.2025.100821_bib38","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1158\/1078-0432.CCR-21-3817","article-title":"Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes","volume":"28","author":"Bolton","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2025.100821_bib39","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"issue":"4","key":"10.1016\/j.modpat.2025.100821_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PGP.0000000000000609","article-title":"Use of immunohistochemical markers (HNF-1beta, Napsin A, ER, CTH, and ASS1) to distinguish endometrial clear cell carcinoma from its morphologic mimics including Arias-Stella reaction","volume":"39","author":"Ji","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100821_bib41","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100821_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2025.100821_bib44","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100821_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111859","article-title":"Genomic heterogeneity as a barrier to precision oncology in urothelial cancer","volume":"41","author":"Clinton","year":"2022","journal-title":"Cell Rep"},{"issue":"13","key":"10.1016\/j.modpat.2025.100821_bib46","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-22-3247","article-title":"Overcoming barriers to tumor genomic profiling through direct-to-patient outreach","volume":"29","author":"Doe-Tetteh","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"7766","key":"10.1016\/j.modpat.2025.100821_bib47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","article-title":"Tumour lineage shapes BRCA-mediated phenotypes","volume":"571","author":"Jonsson","year":"2019","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.modpat.2025.100821_bib48","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.modpat.2025.100821_bib49","series-title":"Calling somatic SNVs and indels with Mutect2","author":"Benjamin","year":"2019"},{"issue":"8","key":"10.1016\/j.modpat.2025.100821_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"issue":"7793","key":"10.1016\/j.modpat.2025.100821_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.modpat.2025.100821_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.19.01395","article-title":"Cancer susceptibility mutations in patients with urothelial malignancies","volume":"38","author":"Carlo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100821_bib53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","article-title":"Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R","volume":"35","author":"Paradis","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.modpat.2025.100821_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","article-title":"Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial","volume":"42","author":"Meric-Bernstam","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100821_bib56","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.juro.2008.08.040","article-title":"Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations","volume":"180","author":"Thomas","year":"2008","journal-title":"J Urol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:32:08Z","timestamp":1779780728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0893395225001188"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100821","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100821"}}